CD274 and toxoplasmosis: The inhibitory receptor PD-1 and its ligand PDL-1 characterize this dysfunction, and PD-1-PDL-1 blockade reinvigorates CD8+ T cell response and further controls toxoplasmosis relapse (Bhadra et al., 2011; Figure 2).